THORNTON JOSEPH CLAY sold $78K of CLOV
THORNTON JOSEPH CLAY (Interim CFO) sold 17,775 shares of CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV) at $4.39 on 2026-08-17 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The newest fact is the specific sale details (shares, price, total value) and confirmation that it was executed under a pre-arranged 10b5-1 plan.
Market read
Traders may monitor insider activity for sentiment, but this filing alone does not provide new fundamental information.
What to watch
The sale size ($78k) is small relative to a public company, and 10b5-1 plans are designed to reduce timing-based inference.
Background
The article is an SEC Form 4 insider transaction for Clover Health Investments Corp. (DE), reported by Interim CFO Thornton Joseph Clay.
Ticker impact
Clover Health insider Thornton Joseph Clay, Interim CFO, sold 17,775 shares at $4.3900 on a 10b5-1 plan filed today.
Likely minimal near-term impact; any reaction would be sentiment-driven rather than a new fundamental catalyst.
The filing is a Form 4 insider transaction with explicit 10b5-1 pre-arrangement, and it does not disclose new operating, financial, or regulatory information.
Market effects
No clear sector read-through because the disclosure is a single-company insider sale without new guidance or events.
None indicated.
None indicated.
Counterpoint
Even with 10b5-1, repeated insider selling can still coincide with internal caution, so traders may treat it as a mild bearish sentiment input.
Key entities
- issuerClover Health Investments Corp. (DE)
Company whose insider transaction was filed on SEC Form 4.
- insiderThornton Joseph Clay
Interim CFO who sold shares via an open-market transaction under a 10b5-1 plan.
